Jinzhou Medical University

This study is testing whether combining a hormone therapy drug (leuprorelin) with an immune-boosting drug (sintilimab) can better control advanced lung cancer. Researchers want to see if the hormone therapy rejuvenates the immune system to make the immunotherapy more effective. T…